Prognostic factors in univariate analysis on acute myelogenous leukemia
| Clinical factor . | No. of patients . | 2-yr survival (%) . | P value . | |
|---|---|---|---|---|
| Wilcoxon test . | Log-rank test . | |||
| Age (y) | ||||
| <60 | 58 | 38.9 | .9124 | .3324 |
| ≧60 | 44 | 7.4 | ||
| Gender | ||||
| Male | 50 | 26.1 | .5303 | .6049 |
| Female | 52 | 24.5 | ||
| WBC (/μL) | ||||
| ≦10 000 | 55 | 30.7 | .0001 | .0001 |
| >10 000, ≦50 000 | 35 | 23.2 | ||
| >50 000 | 12 | 0.0 | ||
| LDH | ||||
| <5× normal | 90 | 28.3 | .0001 | .0001 |
| ≧5× normal | 12 | 0.0 | ||
| Chromosomal aberration | ||||
| Good | 27 | 36.7 | .0536 | .0584 |
| Intermediate | 50 | 26.3 | ||
| Poor | 22 | 14.7 | ||
| nm23-H1 (ng/mL) | ||||
| <80 | 73 | 33.3 | .0001 | .0001 |
| ≧80 | 29 | 0.0 | ||
| Clinical factor . | No. of patients . | 2-yr survival (%) . | P value . | |
|---|---|---|---|---|
| Wilcoxon test . | Log-rank test . | |||
| Age (y) | ||||
| <60 | 58 | 38.9 | .9124 | .3324 |
| ≧60 | 44 | 7.4 | ||
| Gender | ||||
| Male | 50 | 26.1 | .5303 | .6049 |
| Female | 52 | 24.5 | ||
| WBC (/μL) | ||||
| ≦10 000 | 55 | 30.7 | .0001 | .0001 |
| >10 000, ≦50 000 | 35 | 23.2 | ||
| >50 000 | 12 | 0.0 | ||
| LDH | ||||
| <5× normal | 90 | 28.3 | .0001 | .0001 |
| ≧5× normal | 12 | 0.0 | ||
| Chromosomal aberration | ||||
| Good | 27 | 36.7 | .0536 | .0584 |
| Intermediate | 50 | 26.3 | ||
| Poor | 22 | 14.7 | ||
| nm23-H1 (ng/mL) | ||||
| <80 | 73 | 33.3 | .0001 | .0001 |
| ≧80 | 29 | 0.0 | ||
Abbreviations as in Table 3.